Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's …

T Intragumtornchai, U Bunworasate… - Leukemia & …, 2006 - Taylor & Francis
With currently available combination chemotherapy regimens, the outcome of the patients
newly diagnosed with aggressive non-Hodgkin's lymphoma (NHL) identified as 'high'and …
被引用次数：16 相关文章

Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's …

T Intragumtornchai, U Bunworasate… - Leukemia & …, 2006 - search.ebscohost.com
With currently available combination chemotherapy regimens, the outcome of the patients
newly diagnosed with aggressive non-Hodgkin's lymphoma (NHL) identified as' …

Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's …

T Intragumtornchai, U Bunworasate… - Leukemia & …, 2006 - pubmed.ncbi.nlm.nih.gov
With currently available combination chemotherapy regimens, the outcome of the patients
newly diagnosed with aggressive non-Hodgkin's lymphoma (NHL) identified as' …

Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's …

T Intragumtornchai, U Bunworasate… - Leukemia & …, 2006 - europepmc.org
With currently available combination chemotherapy regimens, the outcome of the patients
newly diagnosed with aggressive non-Hodgkin's lymphoma (NHL) identified as' …

[引用][C] Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non …

T INTRAGUMTORNCHAI, U BUNWORASATE… - Leukemia & …, 2006 - Informa